Ben Zipkin

Ben Zipkin is a visionary entrepreneur with a passion for merging technology, data analytics, and healthcare to drive transformative change. As the founder and chief strategist at PharmaForward, he collaborates with biopharma companies to develop cutting-edge marketing strategies, harness artificial intelligence, and elevate user experience design, establishing himself as a prominent industry thought leader.

With a specialized focus on digital analytics within biopharma, Ben excels in areas such as orphan and chronic diseases, gene therapies, precision medicine, and clinical trial recruitment. His knack for identifying pivotal trends and leveraging them to benefit clients and enhance patient outcomes underscores his expertise.

Prior to founding PharmaForward, Ben Zipkin amassed a wealth of experience in digital healthcare. His leadership role as a partner and director of digital services at Cambridge BioMarketing was marked by successful projects and significant contributions to the industry, culminating in the company's acquisition by Evoke.

Driven by an entrepreneurial spirit from an early stage, Ben co-founded RDVO in 2002, a forward-thinking digital strategy and design firm aimed at revolutionizing the digital landscape for clients. Through dedication and a commitment to delivering exceptional value, RDVO flourished into a successful venture before being acquired by Cambridge BioMarketing.

Throughout his professional journey, Ben Zipkin has continuously challenged conventional practices and advocated for innovation. His profound digital strategy acumen combined with a deep understanding of the healthcare sector uniquely equip him to assist clients in navigating the intricate biopharma terrain. At PharmaForward, he continues to pioneer progressive solutions to address the dynamic challenges of the biopharma industry.

Ben pursued his education in English and Journalism at the University of New Hampshire, laying a foundation for his effective communication and storytelling skills that complement his entrepreneurial endeavors.